The FDA, along with the DOJ’s Consumer Protection Branch, mentioned clinical research fraud as an area of heightened concern in late 2019. The COVID-19 pandemic only made the concern more urgent for federal investigators. As of March 2021, more...
The FDA, along with the DOJ’s Consumer Protection Branch, mentioned clinical research fraud as an area of heightened concern in late 2019. The COVID-19 pandemic only made the concern more urgent for federal investigators. As of March 2021, more...